These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 15809678

  • 1. Repeated injections of PEG-PE liposomes generate anti-PEG antibodies.
    Sroda K, Rydlewski J, Langner M, Kozubek A, Grzybek M, Sikorski AF.
    Cell Mol Biol Lett; 2005; 10(1):37-47. PubMed ID: 15809678
    [Abstract] [Full Text] [Related]

  • 2. PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner.
    Ishida T, Wang X, Shimizu T, Nawata K, Kiwada H.
    J Control Release; 2007 Oct 08; 122(3):349-55. PubMed ID: 17610982
    [Abstract] [Full Text] [Related]

  • 3. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes.
    Ishida T, Ichihara M, Wang X, Yamamoto K, Kimura J, Majima E, Kiwada H.
    J Control Release; 2006 May 01; 112(1):15-25. PubMed ID: 16515818
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids.
    Bradley AJ, Devine DV, Ansell SM, Janzen J, Brooks DE.
    Arch Biochem Biophys; 1998 Sep 15; 357(2):185-94. PubMed ID: 9735159
    [Abstract] [Full Text] [Related]

  • 5. Interactions of antigen-sensitized liposomes with immobilized antibody: a homogeneous solid-phase immunoliposome assay.
    Ho RJ, Huang L.
    J Immunol; 1985 Jun 15; 134(6):4035-40. PubMed ID: 3886794
    [Abstract] [Full Text] [Related]

  • 6. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection.
    Laverman P, Carstens MG, Boerman OC, Dams ET, Oyen WJ, van Rooijen N, Corstens FH, Storm G.
    J Pharmacol Exp Ther; 2001 Aug 15; 298(2):607-12. PubMed ID: 11454922
    [Abstract] [Full Text] [Related]

  • 7. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.
    Dams ET, Laverman P, Oyen WJ, Storm G, Scherphof GL, van Der Meer JW, Corstens FH, Boerman OC.
    J Pharmacol Exp Ther; 2000 Mar 15; 292(3):1071-9. PubMed ID: 10688625
    [Abstract] [Full Text] [Related]

  • 8. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.
    Ishida T, Atobe K, Wang X, Kiwada H.
    J Control Release; 2006 Oct 27; 115(3):251-8. PubMed ID: 17045355
    [Abstract] [Full Text] [Related]

  • 9. Cross-reactivity of antibodies raised against acetaldehyde adducts of protein with acetaldehyde adducts of phosphatidyl-ethanolamine: possible role in alcoholic cirrhosis.
    Trudell JR, Ardies CM, Anderson WR.
    Mol Pharmacol; 1990 Nov 27; 38(5):587-93. PubMed ID: 2233695
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Generation, characterization and in vivo biological activity of two distinct monoclonal anti-PEG IgMs.
    Hashimoto Y, Shimizu T, Mima Y, Abu Lila AS, Ishida T, Kiwada H.
    Toxicol Appl Pharmacol; 2014 May 15; 277(1):30-8. PubMed ID: 24632081
    [Abstract] [Full Text] [Related]

  • 12. Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes.
    Ishida T, Ichihara M, Wang X, Kiwada H.
    J Control Release; 2006 Oct 27; 115(3):243-50. PubMed ID: 17011060
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vivo applications of PEG liposomes: unexpected observations.
    Laverman P, Boerman OC, Oyen WJG, Corstens FHM, Storm G.
    Crit Rev Ther Drug Carrier Syst; 2001 Oct 27; 18(6):551-66. PubMed ID: 11789675
    [Abstract] [Full Text] [Related]

  • 17. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes.
    Ishida T, Kiwada H.
    Int J Pharm; 2008 Apr 16; 354(1-2):56-62. PubMed ID: 18083313
    [Abstract] [Full Text] [Related]

  • 18. Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes.
    Hossann M, Syunyaeva Z, Schmidt R, Zengerle A, Eibl H, Issels RD, Lindner LH.
    J Control Release; 2012 Sep 10; 162(2):400-6. PubMed ID: 22759980
    [Abstract] [Full Text] [Related]

  • 19. The effect of methoxy-PEG chain length and molecular architecture on lymph node targeting of immuno-PEG liposomes.
    Moghimi SM.
    Biomaterials; 2006 Jan 10; 27(1):136-44. PubMed ID: 16019063
    [Abstract] [Full Text] [Related]

  • 20. Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives.
    Xu H, Deng Y, Chen D, Hong W, Lu Y, Dong X.
    J Control Release; 2008 Sep 24; 130(3):238-45. PubMed ID: 18657874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.